Reported about 12 hours ago
President Trump's new executive order aims to reduce American prescription drug prices by enforcing 'most favored nation' pricing, aligning costs with those in other developed countries. However, the initiative encounters numerous challenges, including potential legal pushback from the pharmaceutical industry and uncertainties about its implementation. Trump's past attempts to achieve similar goals faced judicial obstacles, and while he remains optimistic about cooperation from drug manufacturers, the industry's initial reactions suggest skepticism about the feasibility and impact of his plan.
Source: YAHOO